Telix Pharmaceuticals | TLX - Pre Tax Profit

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
9.65

Telix Pharmaceuticals reported AUD76.73M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Cochlear AUD 121.1M 155.6M Jun/2025
CSL USD 1.4B 1.14B Jun/2025
Integral Diagnostics AUD 14.49M 47.37M Jun/2024
Mayne Pharma AUD -14.7M 42.91M Dec/2024
Medical Developments International AUD -149K 466K Jun/2025
Mesoblast USD -54.09M 6.37M Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Pacific Edge NZD -714K 49K Mar/2024
Polynovo AUD 1.82M 3.89M Jun/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Ramsay Health Care AUD 103.75M 54.35M Jun/2025
ResMed USD 496.15M 13.77M Dec/2025
Sonic Healthcare AUD 402.01M 53.16M Jun/2025